Does DOFETILIDE Cause Therapy cessation? 59 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Therapy cessation have been filed in association with DOFETILIDE (Dofetilide). This represents 1.2% of all adverse event reports for DOFETILIDE.
59
Reports of Therapy cessation with DOFETILIDE
1.2%
of all DOFETILIDE reports
0
Deaths
36
Hospitalizations
How Dangerous Is Therapy cessation From DOFETILIDE?
Of the 59 reports, 36 (61.0%) required hospitalization, and 1 (1.7%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOFETILIDE. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does DOFETILIDE Cause?
Drug ineffective (654)
Atrial fibrillation (438)
Death (285)
Electrocardiogram qt prolonged (267)
Dyspnoea (230)
Dizziness (228)
Fatigue (180)
Malaise (175)
Headache (154)
Palpitations (128)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which DOFETILIDE Alternatives Have Lower Therapy cessation Risk?
DOFETILIDE vs DOLUTEGRAVIR
DOFETILIDE vs DOLUTEGRAVIR\LAMIVUDINE
DOFETILIDE vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL
DOFETILIDE vs DOLUTEGRAVIR\RILPIVIRINE
DOFETILIDE vs DOMPERIDONE